Public Offerings IPO Process Share Issuance Stock Issuance Offer for Sale Anchor Investors Share Offerings IPO Subscription IPO Proceeds Shareholder Transactions Convertible Notes Preferred Stock Share Sales Shareholder Actions Share Capital Investor Relations Shareholder Relations Stock Sales Capital Raising Debt Financing Private Placement Investment Strategies Stock Options Alternative Investments Fresh Issue of Shares Stock Purchases Stock Buybacks Share Pricing Investment Transactions Share Repurchase Share Allocation IPO Proceeds Allocation Investment Units Debt Management Shareholder Value Share Placement Stake Acquisition Common Stock Preference Shares Public Shareholding Market Trends Shares Qualified Institutional Placement Stock Transactions Mining Public Listings Securities Regulation Stock Market Secondary Offerings Initial Public Offerings IPO Utilization Stock Ratings Share Warrants Shareholder Rights Shareholder Offerings Public Subscription Pre-IPO Placement Share Allotment Government Stake Shareholder Structure HDB Financial Services Stock Listings Capital Markets IPO Valuation Preferred Shares At-the-Market Offerings Dilution Stake Dilution Stake Management Underwriting Convertible Securities IPO Structure Shareholder Distributions Share Buybacks Common Shares Cash Flow Stakeholders Stock Splits Warrants Investment Partnerships
The financing is intended to support clinical work on NVG-291 and company operations using proceeds from a U.S. and Canadian shelf offering.
